08 December 2020
Forbion secures EUR 460 million for oversubscribed fifth fund
07 December 2020
Rexgenero Appoints Sadia L’Baouch as Chief Manufacturing Officer
04 December 2020
SkinBioTherapeutics plc - Full year results 2020
24 November 2020
Stephen Freer appointed Chief Clinical Officer at Ieso
21 October 2020
MammaPrint® Approved for Reimbursement in Germany
21 September 2020
Forbion portfolio company, Inflazome to be acquired by Roche
08 September 2020
Forbion leads US$35M Series B financing round for Inversago Pharma
08 September 2020
SkinBioTherapeutics plc - Appointment of Senior Medical Advisor
14 July 2020
Year end trading update July 2020
16 April 2020
Synthon Biopharmaceuticals relaunches as Byondis
01 April 2020
Introducing Cytiva – Global Life Sciences Leader
25 February 2020
Clinigen Half Year Results
18 February 2020
Interim Results for the six months to 30 November 2019
12 February 2020
Rexgenero Appoints Huw Jones as a Non-Executive Director
10 February 2020
Rexgenero Appoints David Horn Solomon as Chairman
04 February 2020
Healx appoints Dr Anthony Hall as Chief Medical Officer
29 January 2020
Forbion Appoints Dr. John Montana as Operating Partner
16 January 2020
CLINIGEN_Half Year trading update
13 January 2020
Feedback plc licence agreement with Imaging Engineering
07 January 2020
Polyganics Achieves CE Mark Certification for LIQOSEAL®